Found: 90
Select item for more details and to access through your institution.
Polypharmacy in multiple sclerosis: More is not necessarily better.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 1, p. 3, doi. 10.1177/13524585221129964
- By:
- Publication type:
- Article
Impact of mindfulness-based stress reduction for people with multiple sclerosis at 8 weeks and 12 months: A randomized clinical trial.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 8, p. 1178, doi. 10.1177/1352458518786650
- By:
- Publication type:
- Article
A multicenter randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Long-term (12-month) follow-up at one site.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 6, p. 871, doi. 10.1177/1352458518775920
- By:
- Publication type:
- Article
A multicenter randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Short- and medium-term benefits.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 275, doi. 10.1177/1352458517745723
- By:
- Publication type:
- Article
Longitudinal optical coherence tomography study of optic atrophy in secondary progressive multiple sclerosis: Results from a clinical trial cohort.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 1, p. 55, doi. 10.1177/1352458517739136
- By:
- Publication type:
- Article
Differential susceptibility of human Th1 versus T h 2 cells to induction of anergy and apoptosis by ECDI/antigen-coupled antigen-presenting cells.
- Published in:
- International Immunology, 2000, v. 12, n. 1, p. 57, doi. 10.1093/intimm/12.1.57
- By:
- Publication type:
- Article
Mitochondrial dysfunction and neurodegeneration in multiple sclerosis.
- Published in:
- Frontiers in Physiology, 2013, v. 4, p. 1, doi. 10.3389/fphys.2013.00169
- By:
- Publication type:
- Article
Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges.
- Published in:
- Frontiers in Physiology, 2012, v. 3, p. 1, doi. 10.3389/fphys.2012.00285
- By:
- Publication type:
- Article
Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges.
- Published in:
- Frontiers in Physiology, 2012, v. 3, p. 1, doi. 10.3389/fphys.2012.00285
- By:
- Publication type:
- Article
Predicting Falls in People with Multiple Sclerosis: Fall History Is as Accurate as More Complex Measures.
- Published in:
- Multiple Sclerosis International, 2013, p. 1, doi. 10.1155/2013/496325
- By:
- Publication type:
- Article
Focal Increases of Axoplasmic Ca<sup>2+</sup> Aggregation of Sodium-Calcium Exchanger, N-type Ca<sup>2+</sup> Channel, and Actin Define the Sites of Spheroids in Axons Undergoing Oxidative Stress.
- Published in:
- Journal of Neuroscience, 2012, v. 32, n. 35, p. 12028, doi. 10.1523/JNEUROSCI.0408-12.2012
- By:
- Publication type:
- Article
Characteristics of Prescription Drug Use Among Individuals With Multiple Sclerosis in the US Medicare Population.
- Published in:
- International Journal of MS Care, 2022, v. 24, n. 2, p. 90, doi. 10.7224/1537-2073.2021-062
- By:
- Publication type:
- Article
Medications Are Associated with Falls in People with Multiple Sclerosis.
- Published in:
- International Journal of MS Care, 2015, v. 17, n. 5, p. 207, doi. 10.7224/1537-2073.2014-076
- By:
- Publication type:
- Article
Fear of Falling Is Associated with Recurrent Falls in People with Multiple Sclerosis.
- Published in:
- International Journal of MS Care, 2015, v. 17, n. 4, p. 164, doi. 10.7224/1537-2073.2014-042
- By:
- Publication type:
- Article
Antigen-Specific Therapy Promotes Repair of Myelin and Axonal Damage in Established EAE.
- Published in:
- Journal of Neurochemistry, 2006, v. 98, n. 6, p. 1817, doi. 10.1111/j.1471-4159.2006.04081.x
- By:
- Publication type:
- Article
Mapping human brain capillary water lifetime: high-resolution metabolic neuroimaging.
- Published in:
- NMR in Biomedicine, 2015, v. 28, n. 6, p. 607, doi. 10.1002/nbm.3294
- By:
- Publication type:
- Article
Gray matter blood‐brain barrier water exchange dynamics are reduced in progressive multiple sclerosis.
- Published in:
- Journal of Neuroimaging, 2021, v. 31, n. 6, p. 1111, doi. 10.1111/jon.12912
- By:
- Publication type:
- Article
MRI characteristics of Japanese macaque encephalomyelitis: Comparison to human diseases.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Observation of Reduced Homeostatic Metabolic Activity and/or Coupling in White Matter Aging.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Reducing survey burden: feasibility and validity of PROMIS measures in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 8, p. 1102, doi. 10.1177/1352458513517279
- By:
- Publication type:
- Article
Response to comment on letter for: ‘Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients’.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 8, p. 1101, doi. 10.1177/1352458512471874
- By:
- Publication type:
- Article
Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time: No.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 11, p. 1529, doi. 10.1177/1352458512462075
- By:
- Publication type:
- Article
Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 12, p. 1472, doi. 10.1177/1352458511412996
- By:
- Publication type:
- Article
Decreased FOXP3 levels in multiple sclerosis patientsA.A.V. has a significant financial interest in The Immune Response Corporation, a company that may have a commercial interest in the results of this research and technology. This potential conflict of interest has been reviewed and managed by the OHSU and VAMC Conflict of Interest Committees.
- Published in:
- Journal of Neuroscience Research, 2005, v. 81, n. 1, p. 45, doi. 10.1002/jnr.20522
- By:
- Publication type:
- Article
a lipoic acid inhibits human T-cell migration: Implications for multiple sclerosis.
- Published in:
- Journal of Neuroscience Research, 2004, v. 78, n. 3, p. 362, doi. 10.1002/jnr.20255
- By:
- Publication type:
- Article
T‐cell hybridoma specific for myelin oligodendrocyte glycoprotein‐35–55 peptide produced from HLA‐DRB1*1501‐transgenic mice.
- Published in:
- Journal of Neuroscience Research, 2004, v. 77, n. 5, p. 670, doi. 10.1002/jnr.20201
- By:
- Publication type:
- Article
FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: Neuroimmunophilin ligand‐mediated neuroprotection in a model of multiple sclerosis.
- Published in:
- Journal of Neuroscience Research, 2004, v. 77, n. 3, p. 367, doi. 10.1002/jnr.20165
- By:
- Publication type:
- Article
Polypharmacy in Multiple Sclerosis: Prevalence, Risks, and Mitigation Strategies.
- Published in:
- Current Neurology & Neuroscience Reports, 2023, v. 23, n. 9, p. 521, doi. 10.1007/s11910-023-01289-9
- By:
- Publication type:
- Article
Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic Implications.
- Published in:
- Current Neurology & Neuroscience Reports, 2021, v. 21, n. 6, p. 1, doi. 10.1007/s11910-021-01110-5
- By:
- Publication type:
- Article
Using the Anterior Visual System to Assess Neuroprotection and Remyelination in Multiple Sclerosis Trials.
- Published in:
- Current Neurology & Neuroscience Reports, 2018, v. 18, n. 8, p. 1, doi. 10.1007/s11910-018-0858-y
- By:
- Publication type:
- Article
Remyelination and Multiple Sclerosis: Therapeutic Approaches and Challenges.
- Published in:
- Current Neurology & Neuroscience Reports, 2014, v. 14, n. 10, p. 1, doi. 10.1007/s11910-014-0485-1
- By:
- Publication type:
- Article
New Disease-Modifying Therapies and New Challenges for MS.
- Published in:
- Current Neurology & Neuroscience Reports, 2012, v. 12, n. 5, p. 489, doi. 10.1007/s11910-012-0295-2
- By:
- Publication type:
- Article
The Radiologically Isolated Syndrome: Look (Again) Before You Treat.
- Published in:
- Current Neurology & Neuroscience Reports, 2011, v. 11, n. 5, p. 498, doi. 10.1007/s11910-011-0213-z
- By:
- Publication type:
- Article
Cognitive Impairment and MS: Searching for Effective Therapies.
- Published in:
- Current Neurology & Neuroscience Reports, 2011, v. 11, n. 5, p. 451, doi. 10.1007/s11910-011-0217-8
- By:
- Publication type:
- Article
Oral Disease-Modifying Therapies for Multiple Sclerosis: Are We There Yet?
- Published in:
- Current Neurology & Neuroscience Reports, 2010, v. 10, n. 5, p. 333, doi. 10.1007/s11910-010-0126-2
- By:
- Publication type:
- Article
Axonal degeneration in multiple sclerosis: The mitochondrial hypothesis.
- Published in:
- Current Neurology & Neuroscience Reports, 2009, v. 9, n. 5, p. 411, doi. 10.1007/s11910-009-0060-3
- By:
- Publication type:
- Article
Alemtuzumab versus interferon beta-1a in early multiple sclerosis.
- Published in:
- 2009
- By:
- Publication type:
- Report
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
- Published in:
- 2008
- By:
- Publication type:
- Report
Complementary and alternative medicine: Is there a role in multiple sclerosis?
- Published in:
- Current Neurology & Neuroscience Reports, 2006, v. 6, n. 3, p. 259, doi. 10.1007/s11910-006-0014-y
- By:
- Publication type:
- Article
Better Patient Outcomes at Less Cost: An Effective Strategy for Neurology Care.
- Published in:
- Annals of Neurology, 2022, v. 92, n. 2, p. 161, doi. 10.1002/ana.26427
- By:
- Publication type:
- Article
Lipoic Acid Stimulates cAMP Production in Healthy Control and Secondary Progressive MS Subjects.
- Published in:
- Molecular Neurobiology, 2018, v. 55, n. 7, p. 6037, doi. 10.1007/s12035-017-0813-y
- By:
- Publication type:
- Article
Centella asiatica accelerates nerve regeneration upon oral administration and contains multiple active fractions increasing neurite elongation in-vitro.
- Published in:
- Journal of Pharmacy & Pharmacology, 2005, v. 57, n. 9, p. 1221
- By:
- Publication type:
- Article
Enlarged perivascular spaces are not associated with vascular co-morbidities, clinical outcomes, and brain volumes in people with secondary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2020, p. 1, doi. 10.1177/2055217320964502
- By:
- Publication type:
- Article
Enlarged perivascular spaces are not associated with vascular co-morbidities, clinical outcomes, and brain volumes in people with secondary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2020, v. 6, n. 4, p. 1, doi. 10.1177/2055217320964502
- By:
- Publication type:
- Article
Oral lipoic acid as a treatment for acute optic neuritis: a blinded, placebo controlled randomized trial.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 2, p. 1, doi. 10.1177/2055217319850193
- By:
- Publication type:
- Article
Myelin‐specific T cells in animals with Japanese macaque encephalomyelitis.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 2, p. 456, doi. 10.1002/acn3.51303
- By:
- Publication type:
- Article
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.
- Published in:
- Autoimmune Diseases (2090-0422), 2012, p. 1, doi. 10.1155/2012/954739
- By:
- Publication type:
- Article
The Neurologists Perspective: What Do We Know and Where Do We Go?
- Published in:
- Neurorehabilitation & Neural Repair, 1994, v. 8, n. 3, p. 105, doi. 10.1177/136140969400800303
- By:
- Publication type:
- Article